Free Trial

Belite Bio (BLTE) Competitors

Belite Bio logo
$65.10 +1.51 (+2.37%)
Closing price 03:59 PM Eastern
Extended Trading
$65.10 0.00 (0.00%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BLTE vs. ROIV, RGC, ELAN, RVMD, GRFS, TGTX, NUVL, CRSP, RYTM, and LNTH

Should you be buying Belite Bio stock or one of its competitors? The main competitors of Belite Bio include Roivant Sciences (ROIV), Regencell Bioscience (RGC), Elanco Animal Health (ELAN), Revolution Medicines (RVMD), Grifols (GRFS), TG Therapeutics (TGTX), Nuvalent (NUVL), CRISPR Therapeutics (CRSP), Rhythm Pharmaceuticals (RYTM), and Lantheus (LNTH). These companies are all part of the "pharmaceutical products" industry.

Belite Bio vs. Its Competitors

Belite Bio (NASDAQ:BLTE) and Roivant Sciences (NASDAQ:ROIV) are both mid-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, dividends, risk, profitability, institutional ownership, earnings, analyst recommendations and valuation.

Belite Bio has a beta of -1.5, suggesting that its share price is 250% less volatile than the S&P 500. Comparatively, Roivant Sciences has a beta of 1.15, suggesting that its share price is 15% more volatile than the S&P 500.

Belite Bio has higher earnings, but lower revenue than Roivant Sciences. Belite Bio is trading at a lower price-to-earnings ratio than Roivant Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Belite BioN/AN/A-$36.14M-$1.36-47.87
Roivant Sciences$29.05M266.86-$171.98M-$0.25-45.62

In the previous week, Roivant Sciences had 7 more articles in the media than Belite Bio. MarketBeat recorded 10 mentions for Roivant Sciences and 3 mentions for Belite Bio. Roivant Sciences' average media sentiment score of 0.85 beat Belite Bio's score of 0.64 indicating that Roivant Sciences is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Belite Bio
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Roivant Sciences
5 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Belite Bio has a net margin of 0.00% compared to Roivant Sciences' net margin of -225.71%. Roivant Sciences' return on equity of -14.76% beat Belite Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Belite BioN/A -32.07% -30.91%
Roivant Sciences -225.71%-14.76%-13.69%

0.5% of Belite Bio shares are owned by institutional investors. Comparatively, 64.8% of Roivant Sciences shares are owned by institutional investors. 13.3% of Belite Bio shares are owned by insiders. Comparatively, 7.9% of Roivant Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Belite Bio currently has a consensus target price of $96.67, indicating a potential upside of 48.49%. Roivant Sciences has a consensus target price of $16.50, indicating a potential upside of 44.67%. Given Belite Bio's higher possible upside, analysts plainly believe Belite Bio is more favorable than Roivant Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Belite Bio
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00
Roivant Sciences
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
3.25

Summary

Roivant Sciences beats Belite Bio on 11 of the 16 factors compared between the two stocks.

Get Belite Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLTE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BLTE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BLTE vs. The Competition

MetricBelite BioMED IndustryMedical SectorNASDAQ Exchange
Market Cap$2.07B$3.04B$5.59B$9.53B
Dividend YieldN/A2.39%4.71%4.03%
P/E Ratio-47.8721.2227.9619.93
Price / SalesN/A200.39389.5465.88
Price / CashN/A42.5736.3258.75
Price / Book13.798.268.375.77
Net Income-$36.14M-$55.06M$3.25B$259.10M
7 Day Performance4.48%-3.99%-2.50%-3.41%
1 Month Performance12.82%13.86%7.98%8.53%
1 Year Performance33.51%4.02%34.65%15.75%

Belite Bio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BLTE
Belite Bio
1.7755 of 5 stars
$65.10
+2.4%
$96.67
+48.5%
+28.3%$2.07BN/A-47.8710
ROIV
Roivant Sciences
2.5589 of 5 stars
$11.35
-1.7%
$16.50
+45.4%
+6.9%$7.85B$29.05M-45.40860Positive News
Upcoming Earnings
RGC
Regencell Bioscience
0.2628 of 5 stars
$13.80
-8.3%
N/AN/A$7.44BN/A0.0010Positive News
ELAN
Elanco Animal Health
3.269 of 5 stars
$14.59
-2.2%
$16.17
+10.8%
+11.4%$7.41B$4.43B19.729,000Positive News
RVMD
Revolution Medicines
4.4631 of 5 stars
$37.26
-1.7%
$68.91
+84.9%
-19.4%$7.06B$11.58M-9.32250Upcoming Earnings
GRFS
Grifols
3.4436 of 5 stars
$10.09
-0.1%
$10.30
+2.1%
+36.2%$6.94B$7.81B8.6223,822News Coverage
Gap Up
TGTX
TG Therapeutics
3.6517 of 5 stars
$35.99
-2.5%
$43.80
+21.7%
+78.3%$5.86B$329M149.96290Positive News
Upcoming Earnings
NUVL
Nuvalent
3.4085 of 5 stars
$81.94
+0.7%
$119.60
+46.0%
+0.1%$5.85BN/A-18.6740Positive News
CRSP
CRISPR Therapeutics
2.519 of 5 stars
$63.75
-1.6%
$71.31
+11.9%
+0.9%$5.59B$37.31M-14.10460News Coverage
Upcoming Earnings
Gap Up
RYTM
Rhythm Pharmaceuticals
3.1521 of 5 stars
$85.68
-0.9%
$91.93
+7.3%
+75.7%$5.50B$130.13M-30.49140Upcoming Earnings
Insider Trade
LNTH
Lantheus
4.627 of 5 stars
$72.41
-0.7%
$131.20
+81.2%
-35.3%$5.05B$1.53B20.57700Positive News
Upcoming Earnings
Analyst Revision

Related Companies and Tools


This page (NASDAQ:BLTE) was last updated on 7/30/2025 by MarketBeat.com Staff
From Our Partners